Rani Therapeutics Holdings (RANI) Return on Capital Employed (QoQ) (2021 - 2026)

Rani Therapeutics Holdings (RANI) Return on Capital Employed (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Rani Therapeutics Holdings 160.20 Mn 167.33 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 9,278.00
Dec 31, 2025 -97,164.00
Sep 30, 2025 -4.34 Mn
Jun 30, 2025 4.47 Mn
Mar 31, 2025 -23,647.00
Dec 31, 2024 -4,287.00
Sep 30, 2024 -4,056.00
Jun 30, 2024 -3,030.00
Mar 31, 2024 -3,262.00
Dec 31, 2023 -1,689.00
Sep 30, 2023 -1,927.00
Jun 30, 2023 -1,330.00
Mar 31, 2023 -675.00
Dec 31, 2022 -155.00
Sep 30, 2022 786.00
Jun 30, 2022 -1,568.00
Mar 31, 2022 -1,173.00
Dec 31, 2021 205.00